Hormone therapy for the prevention of chronic conditions in postmenopausal women: Recommendations from the US Preventive Services Task Force

被引：94

作者：

Johnson, MS ^{[1
]}

Klein, JD ^{[1
]}

Loveland-Cherry, C ^{[1
]}

Moyer, VA ^{[1
]}

Ockene, JK ^{[1
]}

Petitti, DB ^{[1
]}

Siu, AL ^{[1
]}

Teutsch, SM ^{[1
]}

Yawn, BP ^{[1
]}

机构：

[1] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA

来源：

ANNALS OF INTERNAL MEDICINE | 2005年 / 142卷 / 10期

关键词：

D O I：

10.7326/0003-4819-142-10-200505170-00011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This statement summarizes the U.S. Preventive Services Task Force recommendations on hormone therapy for the prevention of chronic conditions in postmenopausal women and the supporting scientific evidence, and updates the Task Force's 2002 recommendations on hormone replacement therapy. The updated statement is based on the results of the Women's Health Initiative randomized, controlled trial, as well as the information in the 2002 summary of the evidence on this topic, which is available on the USPSTF Web site (www.preventiveservices.ahrq.gov).

引用

页码：855 / 860

页数：6

共 31 条

[1] Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease - Recommendation statement from the Canadian Task Force on Preventive Health Care [J].

Abramson, B .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (09) :1388-1389

[2]

*ACOG TASK FORC HO, 2004, OBSTET GYNECOL S, V104, pS1

[3]

*AM CANC SOC, CANC FACTS FIG 2004

[4] Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].

Anderson, GL ;

Limacher, M ;

Assaf, AR ;

Bassford, T ;

Beresford, SAA ;

Black, H ;

Bonds, D ;

Brunner, R ;

Brzyski, R ;

Caan, B ;

Chlebowski, R ;

Curb, D ;

Gass, M ;

Hays, J ;

Heiss, G ;

Hendrix, S ;

Howard, BV ;

Hsia, J ;

Hubbell, A ;

Jackson, R ;

Johnson, KC ;

Judd, H ;

Kotchen, JM ;

Kuller, L ;

LaCroix, AZ ;

Lane, D ;

Langer, RD ;

Lasser, N ;

Lewis, CE ;

Manson, J ;

Margolis, K ;

Ockene, J ;

O'Sullivan, MJ ;

Phillips, L ;

Prentice, RL ;

Ritenbaugh, C ;

Robbins, J ;

Rossouw, JE ;

Sarto, G ;

Stefanick, ML ;

Van Horn, L ;

Wactawski-Wende, J ;

Wallace, R ;

Wassertheil-Smoller, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712

[5]

[Anonymous], SYSTEMATIC EVIDENCE

[6]

Beral Valerie, 2003, Lancet, V362, P419, DOI 10.1016/S0140-6736(03)14065-2

[7] Screening for osteoporosis in postmenopausal women: Recommendations and rationale [J].

Berg, AO ;

Allan, JD ;

Frame, PS ;

Homer, CJ ;

Johnson, MS ;

Klein, JD ;

Lieu, TA ;

Mulrow, CD ;

Orleans, CT ;

Peipert, JF ;

Pender, NJ ;

Siu, AL ;

Teutsch, SM ;

Westhoff, C ;

Woolf, SH .

ANNALS OF INTERNAL MEDICINE, 2002, 137 (06) :526-528

[8] THE USE OF ESTROGENS AND PROGESTINS AND THE RISK OF BREAST-CANCER IN POSTMENOPAUSAL WOMEN [J].

COLDITZ, GA ;

HANKINSON, SE ;

HUNTER, DJ ;

WILLETT, WC ;

MANSON, JE ;

STAMPFER, MJ ;

HENNEKENS, C ;

ROSNER, B ;

SPEIZER, FE .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (24) :1589-1593

[9] Conjugated equine estrogens and global cognitive function in postmenopausal women - Women's Health Initiative Memory Study [J].

Espeland, MA ;

Rapp, SR ;

Shumaker, SA ;

Brunner, R ;

Manson, JE ;

Sherwin, BB ;

Hsia, J ;

Margolis, KL ;

Hogan, PE ;

Wallace, R ;

Dailey, M ;

Freeman, R ;

Hays, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (24) :2959-2968

[10] HORMONE REPLACEMENT THERAPY AND ENDOMETRIAL CANCER RISK - A METAANALYSIS [J].

GRADY, D ;

GEBRETSADIK, T ;

KERLIKOWSKE, K ;

ERNSTER, V ;

PETITTI, D .

OBSTETRICS AND GYNECOLOGY, 1995, 85 (02) :304-313

← 1 2 3 4 →